The recent availability of generics has certainly accelerated interest, but these are not lifestyle or cosmetic drugs for indiscriminate weight loss
A rat LC-MS/MS and pharmacokinetic study reported approximately 38.4% oral bioavailability
Details of direct and indirect estimates are reported in Supplementary Table 4
Oral semaglutide and compounded tirzepatide are additional options that some patients find more convenient or tolerable
Moreover, regular follow-ups are essential, and supervised use is advised
Fortunately, Canadian GLP-1 options offer a safe, reliable, and more cost-effective alternativeand they are the original, manufacturer-made product, unlike U.S